Peer Review reports
From: A2M is a potential core gene in intrahepatic cholangiocarcinoma
| Original Submission | ||
|---|---|---|
| 3 Mar 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 22 Mar 2021 | Reviewed | Reviewer Report |
| 29 Mar 2021 | Reviewed | Reviewer Report |
| 25 Apr 2021 | Author responded | Author comments - Xiaoli Zhang |
| Resubmission - Version 3 | ||
| 25 Apr 2021 | Submitted | Manuscript version 3 |
| 26 Apr 2021 | Author responded | Author comments - Xiaoli Zhang |
| Resubmission - Version 4 | ||
| 26 Apr 2021 | Submitted | Manuscript version 4 |
| 25 May 2021 | Reviewed | Reviewer Report |
| 1 Jun 2021 | Reviewed | Reviewer Report |
| 12 Jun 2021 | Reviewed | Reviewer Report |
| 28 Jun 2021 | Author responded | Author comments - Xiaoli Zhang |
| Resubmission - Version 5 | ||
| 28 Jun 2021 | Submitted | Manuscript version 5 |
| 20 Aug 2021 | Reviewed | Reviewer Report |
| 28 Aug 2021 | Reviewed | Reviewer Report |
| 16 Sep 2021 | Author responded | Author comments - Xiaoli Zhang |
| Resubmission - Version 6 | ||
| 16 Sep 2021 | Submitted | Manuscript version 6 |
| 6 Nov 2021 | Reviewed | Reviewer Report |
| 16 Nov 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 29 Nov 2021 | Editorially accepted | |
| 3 Jan 2022 | Article published | 10.1186/s12885-021-09070-2 |
You can find further information about peer review here.